Annual Revenue
$16.54 B
+$699.00 M+4.41%
December 31, 2024
Summary
- As of February 6, 2025, TEVA annual revenue is $16.54 billion, with the most recent change of +$699.00 million (+4.41%) on December 31, 2024.
- During the last 3 years, TEVA annual revenue has risen by +$665.00 million (+4.19%).
- TEVA annual revenue is now -24.47% below its all-time high of $21.90 billion, reached on December 31, 2016.
Performance
TEVA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$4.23 B
-$102.00 M-2.36%
December 31, 2024
Summary
- As of February 6, 2025, TEVA quarterly revenue is $4.23 billion, with the most recent change of -$102.00 million (-2.36%) on December 31, 2024.
- Over the past year, TEVA quarterly revenue has increased by +$410.00 million (+10.74%).
- TEVA quarterly revenue is now -34.86% below its all-time high of $6.49 billion, reached on December 31, 2016.
Performance
TEVA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$16.54 B
-$228.00 M-1.36%
December 31, 2024
Summary
- As of February 6, 2025, TEVA TTM revenue is $16.54 billion, with the most recent change of -$228.00 million (-1.36%) on December 31, 2024.
- Over the past year, TEVA TTM revenue has increased by +$540.00 million (+3.37%).
- TEVA TTM revenue is now -29.54% below its all-time high of $23.48 billion, reached on September 30, 2017.
Performance
TEVA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TEVA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.4% | +10.7% | +3.4% |
| 3 y3 years | +4.2% | +11.7% | +7.2% |
| 5 y5 years | -2.0% | -5.0% | -0.7% |
TEVA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.8% | -5.1% | +17.6% | -1.4% | +10.8% |
| 5 y | 5-year | -2.0% | +10.8% | -5.3% | +17.6% | -3.2% | +10.8% |
| alltime | all time | -24.5% | >+9999.0% | -34.9% | >+9999.0% | -29.5% | >+9999.0% |
Teva Pharmaceutical Industries Limited Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $16.54 B(+4.4%) | $4.23 B(-2.4%) | $16.54 B(-1.4%) |
| Sep 2024 | - | $4.33 B(+4.0%) | $16.77 B(+3.0%) |
| Jun 2024 | - | $4.16 B(+9.0%) | $16.29 B(+1.8%) |
| Mar 2024 | - | $3.82 B(-14.3%) | $16.00 B(+1.0%) |
| Dec 2023 | $15.85 B(+6.2%) | $4.46 B(+15.8%) | $15.85 B(+3.8%) |
| Sep 2023 | - | $3.85 B(-0.7%) | $15.27 B(+1.7%) |
| Jun 2023 | - | $3.88 B(+5.9%) | $15.02 B(+0.6%) |
| Mar 2023 | - | $3.66 B(-5.7%) | $14.93 B(+0.0%) |
| Dec 2022 | $14.93 B(-6.0%) | $3.88 B(+8.0%) | $14.92 B(-1.4%) |
| Sep 2022 | - | $3.60 B(-5.0%) | $15.14 B(-1.9%) |
| Jun 2022 | - | $3.79 B(+3.4%) | $15.43 B(-0.8%) |
| Mar 2022 | - | $3.66 B(-10.7%) | $15.56 B(-2.0%) |
| Dec 2021 | $15.88 B(-4.7%) | $4.10 B(+5.5%) | $15.88 B(-2.2%) |
| Sep 2021 | - | $3.89 B(-0.6%) | $16.23 B(-0.6%) |
| Jun 2021 | - | $3.91 B(-1.8%) | $16.32 B(+0.2%) |
| Mar 2021 | - | $3.98 B(-10.6%) | $16.28 B(-2.3%) |
| Dec 2020 | $16.66 B(-1.4%) | $4.45 B(+11.9%) | $16.66 B(-0.1%) |
| Sep 2020 | - | $3.98 B(+2.8%) | $16.67 B(-0.7%) |
| Jun 2020 | - | $3.87 B(-11.2%) | $16.79 B(-1.8%) |
| Mar 2020 | - | $4.36 B(-2.5%) | $17.09 B(+1.2%) |
| Dec 2019 | $16.89 B(-7.6%) | $4.47 B(+9.1%) | $16.88 B(+3.0%) |
| Sep 2019 | - | $4.09 B(-2.0%) | $16.39 B(-2.6%) |
| Jun 2019 | - | $4.18 B(+0.7%) | $16.83 B(-3.0%) |
| Mar 2019 | - | $4.15 B(+4.3%) | $17.35 B(-5.0%) |
| Dec 2018 | $18.27 B(-16.4%) | $3.98 B(-12.2%) | $18.27 B(-4.6%) |
| Sep 2018 | - | $4.53 B(-3.7%) | $19.16 B(-5.4%) |
| Jun 2018 | - | $4.70 B(-7.2%) | $20.25 B(-4.8%) |
| Mar 2018 | - | $5.07 B(+4.1%) | $21.27 B(-2.7%) |
| Dec 2017 | $21.85 B(-0.2%) | $4.87 B(-13.4%) | $21.85 B(-6.9%) |
| Sep 2017 | - | $5.62 B(-1.8%) | $23.48 B(+0.2%) |
| Jun 2017 | - | $5.72 B(+1.2%) | $23.43 B(+3.0%) |
| Mar 2017 | - | $5.65 B(-13.0%) | $22.74 B(+3.8%) |
| Dec 2016 | $21.90 B(+11.5%) | $6.49 B(+16.7%) | $21.90 B(+7.9%) |
| Sep 2016 | - | $5.56 B(+10.4%) | $20.29 B(+3.8%) |
| Jun 2016 | - | $5.04 B(+4.7%) | $19.55 B(+0.4%) |
| Mar 2016 | - | $4.81 B(-1.5%) | $19.48 B(-0.9%) |
| Dec 2015 | $19.65 B(-3.1%) | $4.88 B(+1.2%) | $19.65 B(-1.4%) |
| Sep 2015 | - | $4.82 B(-2.9%) | $19.94 B(-1.2%) |
| Jun 2015 | - | $4.97 B(-0.3%) | $20.17 B(-0.4%) |
| Mar 2015 | - | $4.98 B(-3.6%) | $20.25 B(-0.1%) |
| Dec 2014 | $20.27 B(-0.2%) | $5.17 B(+2.2%) | $20.27 B(-1.3%) |
| Sep 2014 | - | $5.06 B(+0.3%) | $20.53 B(-0.0%) |
| Jun 2014 | - | $5.04 B(+0.9%) | $20.54 B(+0.6%) |
| Mar 2014 | - | $5.00 B(-7.9%) | $20.41 B(+0.5%) |
| Dec 2013 | $20.31 B(-0.0%) | $5.43 B(+7.3%) | $20.31 B(+0.9%) |
| Sep 2013 | - | $5.06 B(+2.7%) | $20.13 B(+0.4%) |
| Jun 2013 | - | $4.92 B(+0.5%) | $20.05 B(-0.3%) |
| Mar 2013 | - | $4.90 B(-6.6%) | $20.12 B(-1.0%) |
| Dec 2012 | $20.32 B(+10.9%) | $5.25 B(+5.6%) | $20.32 B(-2.1%) |
| Sep 2012 | - | $4.97 B(-0.4%) | $20.74 B(+3.1%) |
| Jun 2012 | - | $4.99 B(-2.1%) | $20.12 B(+4.0%) |
| Mar 2012 | - | $5.10 B(-10.1%) | $19.33 B(+5.6%) |
| Dec 2011 | $18.31 B(+13.6%) | $5.68 B(+30.7%) | $18.31 B(+7.4%) |
| Sep 2011 | - | $4.34 B(+3.1%) | $17.05 B(+0.6%) |
| Jun 2011 | - | $4.21 B(+3.2%) | $16.96 B(+2.5%) |
| Mar 2011 | - | $4.08 B(-7.7%) | $16.55 B(+2.6%) |
| Dec 2010 | $16.12 B(+16.0%) | $4.42 B(+4.0%) | $16.12 B(+4.0%) |
| Sep 2010 | - | $4.25 B(+11.8%) | $15.51 B(+4.7%) |
| Jun 2010 | - | $3.80 B(+4.0%) | $14.80 B(+2.8%) |
| Mar 2010 | - | $3.65 B(-3.9%) | $14.40 B(+3.6%) |
| Dec 2009 | $13.90 B(+25.4%) | $3.80 B(+7.1%) | $13.90 B(+7.4%) |
| Sep 2009 | - | $3.55 B(+4.4%) | $12.95 B(+5.8%) |
| Jun 2009 | - | $3.40 B(+8.0%) | $12.24 B(+4.9%) |
| Mar 2009 | - | $3.15 B(+10.5%) | $11.66 B(+5.2%) |
| Dec 2008 | $11.09 B(+17.8%) | $2.85 B(+0.2%) | $11.09 B(+2.5%) |
| Sep 2008 | - | $2.84 B(+0.7%) | $10.81 B(+4.6%) |
| Jun 2008 | - | $2.82 B(+9.8%) | $10.34 B(+4.4%) |
| Mar 2008 | - | $2.57 B(-0.2%) | $9.90 B(+5.2%) |
| Dec 2007 | $9.41 B(+11.9%) | $2.58 B(+8.9%) | $9.41 B(+3.3%) |
| Sep 2007 | - | $2.37 B(-0.8%) | $9.11 B(+0.9%) |
| Jun 2007 | - | $2.39 B(+14.7%) | $9.03 B(+2.4%) |
| Mar 2007 | - | $2.08 B(-8.7%) | $8.82 B(+4.8%) |
| Dec 2006 | $8.41 B(+60.2%) | $2.28 B(-0.4%) | $8.41 B(+11.6%) |
| Sep 2006 | - | $2.29 B(+5.2%) | $7.53 B(+14.8%) |
| Jun 2006 | - | $2.17 B(+29.9%) | $6.56 B(+16.8%) |
| Mar 2006 | - | $1.67 B(+19.4%) | $5.62 B(+7.0%) |
| Dec 2005 | $5.25 B | $1.40 B(+6.3%) | $5.25 B(+1.5%) |
| Sep 2005 | - | $1.32 B(+7.3%) | $5.17 B(+1.4%) |
| Jun 2005 | - | $1.23 B(-6.0%) | $5.10 B(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | $1.30 B(-1.4%) | $5.05 B(+5.3%) |
| Dec 2004 | $4.80 B(+46.5%) | $1.32 B(+6.1%) | $4.80 B(+8.6%) |
| Sep 2004 | - | $1.25 B(+6.0%) | $4.42 B(+10.9%) |
| Jun 2004 | - | $1.18 B(+11.8%) | $3.98 B(+11.5%) |
| Mar 2004 | - | $1.05 B(+11.7%) | $3.57 B(+9.0%) |
| Dec 2003 | $3.28 B(+30.1%) | $942.00 M(+15.9%) | $3.28 B(+5.5%) |
| Sep 2003 | - | $812.60 M(+6.3%) | $3.10 B(+6.2%) |
| Jun 2003 | - | $764.40 M(+0.9%) | $2.92 B(+7.0%) |
| Mar 2003 | - | $757.40 M(-1.7%) | $2.73 B(+8.4%) |
| Dec 2002 | $2.52 B(+21.2%) | $770.20 M(+22.0%) | $2.52 B(+8.8%) |
| Sep 2002 | - | $631.30 M(+10.4%) | $2.32 B(+5.7%) |
| Jun 2002 | - | $572.00 M(+4.9%) | $2.19 B(+2.7%) |
| Mar 2002 | - | $545.10 M(-3.9%) | $2.13 B(+2.6%) |
| Dec 2001 | $2.08 B(+18.7%) | $567.07 M(+12.1%) | $2.08 B(+2.4%) |
| Sep 2001 | - | $505.70 M(-1.5%) | $2.03 B(+2.8%) |
| Jun 2001 | - | $513.59 M(+4.6%) | $1.97 B(+3.7%) |
| Mar 2001 | - | $490.93 M(-5.3%) | $1.90 B(+8.8%) |
| Dec 2000 | $1.75 B(+36.5%) | $518.47 M(+15.2%) | $1.75 B(+8.6%) |
| Sep 2000 | - | $450.05 M(+1.4%) | $1.61 B(+8.7%) |
| Jun 2000 | - | $444.00 M(+31.6%) | $1.48 B(+11.3%) |
| Mar 2000 | - | $337.33 M(-11.2%) | $1.33 B(+3.9%) |
| Dec 1999 | $1.28 B(+14.9%) | $379.90 M(+18.3%) | $1.28 B(+6.9%) |
| Sep 1999 | - | $321.14 M(+9.3%) | $1.20 B(+1.5%) |
| Jun 1999 | - | $293.74 M(+2.1%) | $1.18 B(+4.1%) |
| Mar 1999 | - | $287.62 M(-3.1%) | $1.13 B(+1.7%) |
| Dec 1998 | $1.12 B(-0.1%) | $296.93 M(-2.1%) | $1.12 B(+0.5%) |
| Sep 1998 | - | $303.30 M(+22.7%) | $1.11 B(+1.5%) |
| Jun 1998 | - | $247.10 M(-8.0%) | $1.09 B(-2.1%) |
| Mar 1998 | - | $268.60 M(-8.0%) | $1.12 B(+0.1%) |
| Dec 1997 | $1.12 B(+17.1%) | $291.90 M(+1.8%) | $1.12 B(+1.3%) |
| Sep 1997 | - | $286.70 M(+5.9%) | $1.10 B(+4.8%) |
| Jun 1997 | - | $270.70 M(+1.2%) | $1.05 B(+2.0%) |
| Mar 1997 | - | $267.60 M(-3.6%) | $1.03 B(+8.2%) |
| Dec 1996 | $953.80 M(+17.6%) | $277.70 M(+17.4%) | $953.80 M(-5.8%) |
| Sep 1996 | - | $236.60 M(-5.4%) | $1.01 B(+7.6%) |
| Jun 1996 | - | $250.20 M(+32.2%) | $941.30 M(+11.0%) |
| Mar 1996 | - | $189.30 M(-43.7%) | $847.90 M(+4.5%) |
| Dec 1995 | $811.30 M(+11.4%) | $336.50 M(+103.6%) | $811.30 M(+4.5%) |
| Sep 1995 | - | $165.30 M(+5.4%) | $776.00 M(+2.9%) |
| Jun 1995 | - | $156.80 M(+2.7%) | $754.20 M(+1.3%) |
| Mar 1995 | - | $152.70 M(-49.3%) | $744.30 M(+2.2%) |
| Dec 1994 | $728.30 M(+45.1%) | $301.20 M(+109.9%) | $728.30 M(+30.4%) |
| Sep 1994 | - | $143.50 M(-2.3%) | $558.40 M(+3.0%) |
| Jun 1994 | - | $146.90 M(+7.5%) | $542.10 M(+4.2%) |
| Mar 1994 | - | $136.70 M(+4.1%) | $520.20 M(+3.6%) |
| Dec 1993 | $502.00 M(+26.7%) | $131.30 M(+3.2%) | $501.90 M(+2.0%) |
| Sep 1993 | - | $127.20 M(+1.8%) | $492.10 M(+7.5%) |
| Jun 1993 | - | $125.00 M(+5.6%) | $457.90 M(+7.5%) |
| Mar 1993 | - | $118.40 M(-2.6%) | $425.90 M(+6.4%) |
| Dec 1992 | $396.30 M(+21.2%) | $121.50 M(+30.6%) | $400.40 M(+10.7%) |
| Sep 1992 | - | $93.00 M(0.0%) | $361.60 M(+4.1%) |
| Jun 1992 | - | $93.00 M(+0.1%) | $347.30 M(+4.6%) |
| Mar 1992 | - | $92.90 M(+12.3%) | $332.10 M(+1.7%) |
| Dec 1991 | $327.10 M(-0.6%) | $82.70 M(+5.1%) | $326.50 M(-14.9%) |
| Sep 1991 | - | $78.70 M(+1.2%) | $383.70 M(+4.4%) |
| Jun 1991 | - | $77.80 M(-10.9%) | $367.60 M(+2.3%) |
| Mar 1991 | - | $87.30 M(-37.6%) | $359.40 M(+6.4%) |
| Dec 1990 | $329.00 M(+17.0%) | $139.90 M(+123.5%) | $337.80 M(+19.3%) |
| Sep 1990 | - | $62.60 M(-10.1%) | $283.20 M(-0.4%) |
| Jun 1990 | - | $69.60 M(+5.9%) | $284.40 M(+0.3%) |
| Mar 1990 | - | $65.70 M(-23.0%) | $283.60 M(-0.9%) |
| Dec 1989 | $281.10 M(+33.2%) | $85.30 M(+33.7%) | $286.10 M(+7.1%) |
| Sep 1989 | - | $63.80 M(-7.3%) | $267.20 M(+6.9%) |
| Jun 1989 | - | $68.80 M(+0.9%) | $250.00 M(+8.1%) |
| Mar 1989 | - | $68.20 M(+2.7%) | $231.30 M(+8.5%) |
| Dec 1988 | $211.10 M(+51.2%) | $66.40 M(+42.5%) | $213.10 M(+45.3%) |
| Sep 1988 | - | $46.60 M(-7.0%) | $146.70 M(+14.1%) |
| Jun 1988 | - | $50.10 M(+0.2%) | $128.60 M(+22.6%) |
| Mar 1988 | - | $50.00 M(+75.4%) | $104.90 M(-15.9%) |
| Sep 1987 | - | $28.50 M(+8.0%) | $124.70 M(-4.9%) |
| Jun 1987 | - | $26.40 M(-24.4%) | $131.10 M(-6.1%) |
| Mar 1987 | $139.60 M(+53.1%) | $34.90 M(0.0%) | $139.60 M(+9.5%) |
| Dec 1986 | - | $34.90 M(0.0%) | $127.50 M(+10.5%) |
| Sep 1986 | - | $34.90 M(0.0%) | $115.40 M(+11.7%) |
| Jun 1986 | - | $34.90 M(+53.1%) | $103.30 M(+13.3%) |
| Mar 1986 | $91.20 M | $22.80 M(0.0%) | $91.20 M(+33.3%) |
| Dec 1985 | - | $22.80 M(0.0%) | $68.40 M(+50.0%) |
| Sep 1985 | - | $22.80 M(0.0%) | $45.60 M(+100.0%) |
| Jun 1985 | - | $22.80 M | $22.80 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual revenue?
- What is the all time high annual revenue for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual revenue year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly revenue?
- What is the all time high quarterly revenue for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly revenue year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM revenue?
- What is the all time high TTM revenue for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM revenue year-on-year change?
What is Teva Pharmaceutical Industries Limited annual revenue?
The current annual revenue of TEVA is $16.54 B
What is the all time high annual revenue for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual revenue is $21.90 B
What is Teva Pharmaceutical Industries Limited annual revenue year-on-year change?
Over the past year, TEVA annual revenue has changed by +$699.00 M (+4.41%)
What is Teva Pharmaceutical Industries Limited quarterly revenue?
The current quarterly revenue of TEVA is $4.23 B
What is the all time high quarterly revenue for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly revenue is $6.49 B
What is Teva Pharmaceutical Industries Limited quarterly revenue year-on-year change?
Over the past year, TEVA quarterly revenue has changed by +$410.00 M (+10.74%)
What is Teva Pharmaceutical Industries Limited TTM revenue?
The current TTM revenue of TEVA is $16.54 B
What is the all time high TTM revenue for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM revenue is $23.48 B
What is Teva Pharmaceutical Industries Limited TTM revenue year-on-year change?
Over the past year, TEVA TTM revenue has changed by +$540.00 M (+3.37%)